These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 26181555

  • 1. Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis: A Retrospective Study.
    Park VY, Kim EK, Lee HS, Moon HJ, Yoon JH, Kwak JY.
    Medicine (Baltimore); 2015 Jul; 94(28):e1149. PubMed ID: 26181555
    [Abstract] [Full Text] [Related]

  • 2. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
    Lin KL, Wang OC, Zhang XH, Dai XX, Hu XQ, Qu JM.
    Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
    [Abstract] [Full Text] [Related]

  • 3. The thyroid imaging reporting and data system on US, but not the BRAFV600E mutation in fine-needle aspirates, is associated with lateral lymph node metastasis in PTC.
    Park VY, Kim EK, Moon HJ, Yoon JH, Kwak JY.
    Medicine (Baltimore); 2016 Jul; 95(29):e4292. PubMed ID: 27442672
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C, Guo Y, Lv Y, Nanding A, Shi T, Qin H, He J.
    PLoS One; 2016 Jul; 11(12):e0167414. PubMed ID: 27936049
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma.
    Yang Y, Chen C, Chen Z, Jiang J, Chen Y, Jin L, Guo G, Zhang X, Ye T.
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):282-8. PubMed ID: 24483297
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis.
    Bernstein J, Virk RK, Hui P, Prasad A, Westra WH, Tallini G, Adeniran AJ, Udelsman R, Sasaki CT, Roman SA, Sosa JA, Prasad ML.
    Thyroid; 2013 Dec; 23(12):1525-31. PubMed ID: 23682579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
    Park AY, Son EJ, Kim JA, Youk JH, Park YJ, Park CS, Chang HS.
    PLoS One; 2014 Dec; 9(10):e110868. PubMed ID: 25337709
    [Abstract] [Full Text] [Related]

  • 14. Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.
    Li C, Aragon Han P, Lee KC, Lee LC, Fox AC, Beninato T, Thiess M, Dy BM, Sebo TJ, Thompson GB, Grant CS, Giordano TJ, Gauger PG, Doherty GM, Fahey TJ, Bishop J, Eshleman JR, Umbricht CB, Schneider EB, Zeiger MA.
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3702-12. PubMed ID: 23969188
    [Abstract] [Full Text] [Related]

  • 15. BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer.
    Howell GM, Nikiforova MN, Carty SE, Armstrong MJ, Hodak SP, Stang MT, McCoy KL, Nikiforov YE, Yip L.
    Ann Surg Oncol; 2013 Jan; 20(1):47-52. PubMed ID: 22941165
    [Abstract] [Full Text] [Related]

  • 16. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma.
    Kwak JY, Kim EK, Chung WY, Moon HJ, Kim MJ, Choi JR.
    Radiology; 2009 Dec; 253(3):854-60. PubMed ID: 19710001
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.
    Choi SY, Park H, Kang MK, Lee DK, Lee KD, Lee HS, Kim SW, Lee EN, Hong JC.
    World J Surg Oncol; 2013 Nov 14; 11():291. PubMed ID: 24228637
    [Abstract] [Full Text] [Related]

  • 20. BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.
    Ma YJ, Deng XL, Li HQ.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Aug 14; 35(4):591-599. PubMed ID: 26223933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.